10-Q: NaturalShrimp Enters Liquidation, Plans Pivot to Aquaculture Tech

NaturalShrimp Incorporated has filed its Q2 2025 10-Q, detailing its transition to a liquidation basis of accounting following a receivership and asset sale, while also announcing a potential pivot to aquaculture and water treatment technologies.

Summary

• NaturalShrimp Incorporated is operating under a liquidation basis of accounting as of September 30, 2025, due to a receivership initiated in September 2024.
• The company's assets were sold to creditors Streeterville Capital, LLC and Bucktown Capital, LLC for approximately $35.7 million via a credit bid and $100,000 cash, with asset title transferring on May 14, 2025.
• As of September 30, 2025, the company reported net liabilities in liquidation of $8,875,938, a slight increase from $8,791,012 as of March 31, 2025.
• For the six months ended September 30, 2024, under a going concern basis, the company reported a net loss of $3,914,477 on sales of $106,991.
• A significant development is a subsequent event in March 2026, where NaturalShrimp entered an agreement to transition operations towards commercializing aquaculture and water treatment technologies, involving an intellectual property acquisition from Hydrenesis, Inc.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this filing negatively due to the company's liquidation status, sale of assets to creditors, and persistent material weaknesses in internal controls, despite a potential strategic pivot.

Positives

• The company has entered into an agreement to transition its operations towards commercialization of aquaculture and water treatment technologies, signaling a potential new direction.
• Existing liabilities and legacy securities are slated for restructuring, amendment, cancellation, or exchange into Series L Preferred Stock, aiming to simplify the capital structure.
• The company's outstanding obligation to Hydrenesis, Inc. of approximately $1,034,112 will be converted into equity at closing of the agreement.

Negatives

• The company is in liquidation, with net liabilities in liquidation totaling $8,875,938 as of September 30, 2025.
• The company's primary operating assets were transferred to creditors in May 2025 to settle outstanding debt.
• The company reported a net loss of $3,914,477 for the six months ended September 30, 2024.
• Material weaknesses in internal control over financial reporting persist, including inadequate segregation of duties, lack of an independent board and audit committee oversight, and insufficient risk assessment procedures.

Risks

• The company is in liquidation, and its ability to settle remaining liabilities is uncertain.
• The date by which the liquidation is expected to be completed is uncertain.
• The agreement with Hydrenesis, Inc. was not yet consummated as of the filing date, introducing execution risk.
• The company has identified material weaknesses in its internal control over financial reporting, which could lead to misstatements in financial reporting.
• The company's historical operations were in biotechnology, and the transition to aquaculture and water treatment technologies represents a significant strategic shift with inherent execution risks.

Future Outlook

The company's future outlook is tied to the consummation of an agreement with Hydrenesis, Inc. to transition operations towards the commercialization of aquaculture and water treatment technologies. This agreement involves the transfer of intellectual property to NaturalShrimp and the conversion of an outstanding obligation to equity. The company has also approved new preferred stock designations (Series P, P-2, and L) and plans to restructure, amend, cancel, or exchange existing liabilities and securities into Series L Preferred Stock. However, the company is currently in liquidation, and the completion of the Hydrenesis agreement is pending.

Management Comments

• Management acknowledges material weaknesses in internal control over financial reporting, including inadequate segregation of duties, lack of independent board and audit committee oversight, and insufficient risk assessment procedures.
• Management states that as of September 30, 2025, disclosure controls and procedures were not effective due to these material weaknesses.
• Management is committed to taking further action and implementing additional enhancements or improvements to internal controls as necessary and as funds allow.

Industry Context

StockSavvy.ai notes that NaturalShrimp's situation reflects a common challenge for early-stage or struggling companies: the need for significant restructuring or a pivot to survive. The proposed transition into aquaculture and water treatment technologies aligns with growing global interest in sustainable food production and water management, but the company's current liquidation status and past operational issues present substantial hurdles.

Corporate Governance

Legal Proceedings

• The company was not involved in any legal proceedings as of the date of the filing, other than the process of settling its remaining outstanding debts.
• The outstanding legal proceeding with Streeterville and Buckstown was considered settled upon the transfer of its assets to those entities in settlement of its outstanding debt.

Related Party Transactions

• Interest expense - related parties was $20,496 for the six months ended September 30, 2024.
• Of the approximately $8.9 million in outstanding liabilities as of September 30, 2025, approximately $3.0 million was to related parties.

Stakeholder Impact

• Shareholders: The company is in liquidation, and the value of existing shares is likely to be significantly diminished or eliminated.
• Creditors: The primary creditors (Streeterville and Buckstown) have taken possession of the company's assets to satisfy their claims, though remaining liabilities exist.
• Employees: The company's operational status and future employment prospects are uncertain given the liquidation and pending strategic transition.
• Service Providers: Outstanding liabilities include payables to finance and legal service providers.

Next Steps

• Consummation of the Intellectual Property Acquisition and Management Transition Agreement with Hydrenesis, Inc.
• Filing of Certificates of Designation for Series P, Series P-2, and Series L Preferred Stock with the Nevada Secretary of State.
• Restructuring, amendment, cancellation, or exchange of existing liabilities, obligations, and legacy securities into Series L Preferred Stock.
• Continued efforts to settle remaining outstanding liabilities.
• Ongoing monitoring and evaluation of the effectiveness of internal controls and procedures.

Key Dates

Keywords

NaturalShrimp, 10-Q, Liquidation, Receivership, Asset Sale, Aquaculture, Water Treatment, Hydrenesis, Financial Statements, Net Liabilities, Going Concern, Internal Controls